A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer
暂无分享，去创建一个
M. Harrison | A. Armstrong | Jiaoti Huang | Yuan Wu | J. Somarelli | S. Halabi | J. Staats | T. Oyekunle | L. Howard | Tian Zhang | L. Brown | M. Anand | Michael S. Humeniuk | Catrin Davies | Daniel J. George | K. Weinhold | Prekshaben Patel | Jason A. Somarelli | M. Humeniuk